BioPharma Credit (BPCR) Stock Chart & Stock Price History GBX 0.89 +0.00 (+0.23%) As of 11:52 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock BioPharma Credit Stock Price Performance The BioPharma Credit (BPCR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 4.11%, with a year-to-date return of 0.23%. In the past month, the stock has increased 0.68%, reflecting recent market activity. As of the latest close, BioPharma Credit traded at GBX 0.88 with a market cap of £1.05 billion and volume of 1.44 million shares. Five years ago, the stock traded at GBX 1.02, representing a 13.14% decrease over that period. At the time, it had a market cap of £14.01 million and a volume of 885,554 shares. Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.78%1 Month Performance+0.68%3 Month Performance+0.23%Year-To-Date Performance+0.23%1 Year Performance-4.11%5 Year Performance-13.14% BPCR Stock Chart for Thursday, August, 14, 2025 BPCR Chart by TradingView BioPharma Credit Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025GBX 0.87GBX 0.88+1.14%GBX 0.89GBX 0.881.44 million shs£1.05 billion08/12/2025GBX 0.86GBX 0.87+1.39%GBX 0.88GBX 0.861.45 million shs£1.04 billion08/11/2025GBX 0.86GBX 0.86GBX 0.88GBX 0.861.87 million shs£1.02 billion08/08/2025GBX 0.86GBX 0.86GBX 0.87GBX 0.861.53 million shs£1.02 billion08/07/2025GBX 0.86GBX 0.86-0.23%GBX 0.88GBX 0.86410,785 shs£1.02 billion08/06/2025GBX 0.87GBX 0.86-0.92%GBX 0.88GBX 0.86224,385 shs£1.03 billion08/05/2025GBX 0.87GBX 0.87+0.46%GBX 0.87GBX 0.87223,748 shs£1.04 billion08/04/2025GBX 0.87GBX 0.87-0.23%GBX 0.88GBX 0.86232,010 shs£1.03 billion08/01/2025GBX 0.87GBX 0.87+0.23%GBX 0.87GBX 0.86594,452 shs£1.03 billion07/31/2025GBX 0.87GBX 0.87-0.69%GBX 0.88GBX 0.871.17 million shs£1.03 billion Get the Latest News and Ratings for BPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025GBX 0.87GBX 0.87+0.46%GBX 0.88GBX 0.86895,644 shs£1.04 billion07/29/2025GBX 0.87GBX 0.87-0.46%GBX 0.88GBX 0.871.08 million shs£1.03 billion07/28/2025GBX 0.87GBX 0.87+0.46%GBX 0.88GBX 0.87340,206 shs£1.04 billion07/25/2025GBX 0.87GBX 0.87-0.46%GBX 0.88GBX 0.871.41 million shs£1.03 billion07/24/2025GBX 0.88GBX 0.87-0.23%GBX 0.88GBX 0.871.86 million shs£1.04 billion07/23/2025GBX 0.88GBX 0.88-0.23%GBX 0.88GBX 0.88400,682 shs£1.04 billion07/22/2025GBX 0.88GBX 0.88-0.23%GBX 0.89GBX 0.88565,088 shs£1.04 billion07/21/2025GBX 0.88GBX 0.88-0.23%GBX 0.89GBX 0.88747,994 shs£1.04 billion07/18/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88693,544 shs£1.05 billion07/17/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88263,028 shs£1.05 billion07/16/2025GBX 0.88GBX 0.88+0.23%GBX 0.88GBX 0.88284,453 shs£1.05 billion07/15/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.87315,389 shs£1.04 billion07/14/2025GBX 0.87GBX 0.88+0.69%GBX 0.88GBX 0.871.61 million shs£1.04 billion Related Companies abrdn Stock Price Chart 3i Infrastructure Stock Price Chart Petershill Partners Stock Price Chart JPMorgan Global Growth & Income Stock Price Chart RIT Capital Partners Stock Price Chart Bridgepoint Group Stock Price Chart Burford Capital Stock Price Chart Monks Stock Price Chart HarbourVest Global Private Equity Stock Price Chart City of London Stock Price Chart Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BPCR) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access